Results 91 to 100 of about 8,412,464 (305)

Portal hypertension is associated with modulation of regulatory T cells

open access: yesEuropean Journal of Inflammation, 2016
Background: Portal hypertension is a complication of liver cirrhosis. The portal vein drains the spleen and the intestines, which are both rich in inflammatory mediators.
Tomer Adar   +9 more
doaj   +1 more source

Evaluation of liver stiffness measurement–based scores in liver transplantation recipients

open access: yesLiver Transplantation, EarlyView., 2022
Abstract Combining bioclinical parameters with liver stiffness measurement (LSM) has improved the diagnostic performance of vibration‐controlled transient elastography (VCTE) for detection of advanced fibrosis in patients with chronic liver disease. However, this approach has not yet been tested in liver transplantation (LT) recipients.
Tamoore Arshad   +11 more
wiley   +1 more source

Pharmacological Management of Portal Hypertension: A Review Article [PDF]

open access: yesZagazig University Medical Journal
Background: Portal Hypertension is considered an abnormal elevation of pressure in the veins that drain blood from the visceral organs (e.g., the spleen) to the liver.
Mennatullah ELnaggar   +3 more
doaj   +1 more source

Prevalence of hypertension in low- and middle-income countries [PDF]

open access: yes, 2015
We aimed to obtain overall and regional estimates of hypertension prevalence, and to examine the pattern of this disease condition across different socio-demographic characteristics in low-and middle-income countries.We searched electronic databases from
Sarki, Ahmed M.   +9 more
core   +1 more source

Portopulmonary hypertension practice patterns after liver transplantation

open access: yesLiver Transplantation, EarlyView., 2022
Abstract Portopulmonary hypertension (POPH) is a type of pulmonary arterial hypertension occurring exclusively in those with portal hypertensive liver disease. Liver transplantation (LT) can significantly improve outcomes. Current guidelines counsel against immediate adjustments to targeted therapy after LT and suggest routine echocardiography as ...
Arun Jose   +3 more
wiley   +1 more source

Percutaneous transhepatic portal vein stenting in a patient with benign non-transplant postoperative portal vein stenosis: A case report

open access: yesIndian Journal of Radiology and Imaging, 2013
Extrahepatic portal vein stenosis is caused by a variety of benign and malignant diseases and results in development of symptoms due to portal hypertension.
KS Madhusudhan   +4 more
doaj   +1 more source

portal hypertension

open access: yes, 2004
Portal hypertension is a common syndrome with serious clinical consequences. Some aspects of pathophysiology, causes and clinical features are discussed.
Martinelli, Ana L. Candolo
core   +1 more source

Hyperammonemia of unknown origin

open access: yesClinical Management Issues, 2015
Idiopathic portal hypertension is a benign long-standing non-cirrhotic portal hypertension with no typical laboratory findings and absence of stigmata of chronic liver disease.
Francesca Molino
doaj   +1 more source

Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension

open access: yes, 2009
BACKGROUND/AIMS: Angiogenesis is a pathological hallmark of portal hypertension. Although VEGF is considered to be the most important proangiogenic factor in neoangiogenesis, this process requires the coordinated action of a variety of factors ...
Berzigotti, Annalisa   +6 more
core   +1 more source

Korea hypertension fact sheet 2018 [PDF]

open access: yes, 2018
Background: The Korea Hypertension Fact Sheet 2018 aims to overview the magnitude and management status of hypertension, and their trends in Korea. Methods: The Hypertension Epidemiology Research Group analyzed the 1998-2016 Korea National Health and ...
김현창
core   +1 more source

Home - About - Disclaimer - Privacy